Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of subcutaneous BT061 in rheumatoid arthritis patients on methotrexate
2010-018485-24Phase 2Completed
- Sponsor
- Biotest AG
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing BT061 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response. Started Aug 2010; status: completed.
02
Drugs
tregalizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-018485-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018485-24.